{"id":"https://openalex.org/W1984435193","doi":"https://doi.org/10.1158/1538-7445.am2012-2788","title":"Abstract 2788: GTx-230: an orally available novel tubulin inhibitor that disrupts tumor vasculature and displays single-agent antitumor efficacy in multidrug-resistant prostate cancer with less neurotoxicity","display_name":"Abstract 2788: GTx-230: an orally available novel tubulin inhibitor that disrupts tumor vasculature and displays single-agent antitumor efficacy in multidrug-resistant prostate cancer with less neurotoxicity","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W1984435193","doi":"https://doi.org/10.1158/1538-7445.am2012-2788","mag":"1984435193"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-2788","doi":"https://doi.org/10.1158/1538-7445.am2012-2788","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-2788","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027714559","display_name":"Sunjoo Ahn","orcid":"https://orcid.org/0000-0002-6519-6492","observed_orcids":["https://orcid.org/0000-0002-6519-6492"]},"institutions":[{"id":"https://openalex.org/I188703185","display_name":"GTx (United States)","ror":"https://ror.org/0400j3f74","country_code":"US","type":"company","lineage":["https://openalex.org/I188703185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sunjoo Ahn","raw_affiliation_strings":["1GTx Inc, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1GTx Inc, Memphis, TN","institution_ids":["https://openalex.org/I188703185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020933553","display_name":"Chien\u2010Ming Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188703185","display_name":"GTx (United States)","ror":"https://ror.org/0400j3f74","country_code":"US","type":"company","lineage":["https://openalex.org/I188703185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chien-Ming Li","raw_affiliation_strings":["1GTx Inc, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1GTx Inc, Memphis, TN","institution_ids":["https://openalex.org/I188703185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014578708","display_name":"Christina M. Barrett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188703185","display_name":"GTx (United States)","ror":"https://ror.org/0400j3f74","country_code":"US","type":"company","lineage":["https://openalex.org/I188703185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina M. Barrett","raw_affiliation_strings":["1GTx Inc, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1GTx Inc, Memphis, TN","institution_ids":["https://openalex.org/I188703185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100410497","display_name":"Jianjun Chen","orcid":"https://orcid.org/0000-0002-0293-4574","observed_orcids":["https://orcid.org/0000-0002-0293-4574"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianjun Chen","raw_affiliation_strings":["2University of Tennessee, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Tennessee, Memphis, TN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318325","display_name":"W\u011bi Li","orcid":"https://orcid.org/0000-0002-9522-4474","observed_orcids":["https://orcid.org/0000-0002-9522-4474","https://orcid.org/0000-0003-4136-3409","https://orcid.org/0009-0009-9141-6389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["2University of Tennessee, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Tennessee, Memphis, TN","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yan Lu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Lu","raw_affiliation_strings":["2University of Tennessee, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Tennessee, Memphis, TN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016676195","display_name":"Duane D. Miller","orcid":"https://orcid.org/0000-0002-6093-0985","observed_orcids":["https://orcid.org/0000-0002-6093-0985"]},"institutions":[{"id":"https://openalex.org/I188703185","display_name":"GTx (United States)","ror":"https://ror.org/0400j3f74","country_code":"US","type":"company","lineage":["https://openalex.org/I188703185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Duane D. Miller","raw_affiliation_strings":["1GTx Inc, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1GTx Inc, Memphis, TN","institution_ids":["https://openalex.org/I188703185"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002243266","display_name":"James T. Dalton","orcid":"https://orcid.org/0000-0002-3915-7326","observed_orcids":["https://orcid.org/0000-0002-3915-7326"]},"institutions":[{"id":"https://openalex.org/I188703185","display_name":"GTx (United States)","ror":"https://ror.org/0400j3f74","country_code":"US","type":"company","lineage":["https://openalex.org/I188703185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James T. Dalton","raw_affiliation_strings":["1GTx Inc, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1GTx Inc, Memphis, TN","institution_ids":["https://openalex.org/I188703185"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"2788","last_page":"2788"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.382099986076355,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.382099986076355,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.1889999955892563,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.1526000052690506,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tubulin-polymerization-inhibitors","display_name":"tubulin polymerization inhibitors","score":0.8330000042915344},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8510000109672546},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9879999756813049},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9309999942779541},{"id":"https://openalex.org/keywords/colchicine-site","display_name":"colchicine site","score":0.6809999942779541},{"id":"https://openalex.org/keywords/microtubule-destabilization","display_name":"microtubule destabilization","score":0.8479999899864197},{"id":"https://openalex.org/keywords/vascular-disrupting-agents","display_name":"vascular disrupting agents","score":0.6380000114440918},{"id":"https://openalex.org/keywords/tumor-vasculature","display_name":"tumor vasculature","score":0.7559999823570251},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8240000009536743},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9589999914169312},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.8690000176429749},{"id":"https://openalex.org/keywords/peripheral-neuropathy","display_name":"peripheral neuropathy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/vascular-permeability","display_name":"vascular permeability","score":0.843999981880188},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.5630000233650208},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7447765469551086},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7036654353141785},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6111383438110352},{"id":"https://openalex.org/C2779723316","wikidata":"https://www.wikidata.org/wiki/Q6459234","display_name":"LNCaP","level":4,"score":0.6055232286453247},{"id":"https://openalex.org/C2776636253","wikidata":"https://www.wikidata.org/wiki/Q326224","display_name":"Colchicine","level":2,"score":0.5180080533027649},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.477298378944397},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.4766329526901245},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4579668343067169},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.43927279114723206},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.39898237586021423},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.264388769865036},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18411466479301453},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16343554854393005},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1452898383140564},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1417485475540161},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-2788","doi":"https://doi.org/10.1158/1538-7445.am2012-2788","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-2788","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2048106651","https://openalex.org/W2168784593","https://openalex.org/W2093183524","https://openalex.org/W4362594224","https://openalex.org/W1973975360","https://openalex.org/W2038340789","https://openalex.org/W2019009849","https://openalex.org/W2136763947","https://openalex.org/W2128043285","https://openalex.org/W2464971641"],"abstract_inverted_index":{"Abstract":[0],"A":[1],"novel":[2],"indole":[3],"antimitotic":[4,139,228],"compound,":[5],"GTx-230,":[6],"was":[7,107,118,141],"identified":[8],"in":[9,19,43,109,126,144,181,195,212,215],"cell-based":[10],"screening":[11],"assays":[12],"that":[13,162,222],"binds":[14],"to":[15,75,206],"the":[16,27,42,77,145,176,210,251,256],"colchicine":[17],"site":[18],"tubulin":[20],"and":[21,32,58,88,99,159,202,214],"destabilizes":[22],"microtubules.":[23],"In":[24,111,134,149,172,208],"this":[25],"study,":[26],"pharmacokinetics,":[28],"antitumor":[29,217],"efficacy,":[30],"neurotoxicity,":[31],"vascular":[33,183],"disrupting":[34],"ability":[35],"of":[36,46,49,82,92,105,152,169,178,219,232,250,255],"GTx-230":[37,40,93,106,113,163,179,193,220],"were":[38,94],"evaluated.":[39],"inhibited":[41],"vitro":[44,182,213],"growth":[45,124],"a":[47,69,137,186,226],"number":[48],"human":[50],"cancer":[51,61],"cell":[52],"lines":[53],"including":[54],"DU-145,":[55],"LNCaP,":[56],"PC-3,":[57],"PPC-1":[59],"prostate":[60],"cells":[62,131],"with":[63,120,189,238],"low":[64],"nanomolar":[65],"IC50":[66],"values.":[67],"Following":[68],"10":[70],"mg/kg":[71],"intravenous":[72],"(i.v.)":[73],"dose":[74],"mice,":[76],"plasma":[78],"clearance":[79],"(CL),":[80],"volume":[81],"distribution":[83],"at":[84],"steady":[85],"state":[86],"(Vdss),":[87],"terminal":[89],"half-life":[90],"(T1/2)":[91],"19":[95],"ml/min/kg,":[96],"2.9":[97],"l/kg,":[98],"1.7":[100],"h,":[101],"respectively.":[102],"Oral":[103],"bioavailability":[104],"36%":[108],"mice.":[110],"vivo,":[112],"(6.7":[114],"mg/kg,":[115],"qd,":[116],"p.o.)":[117],"effective":[119,143],"near":[121],"100%":[122],"tumor":[123],"inhibition":[125],"xenograft":[127,147],"models":[128],"using":[129,185],"PC-3/TXR":[130,146],"over-expressing":[132],"P-glycoprotein.":[133],"contrast,":[135],"docetaxel,":[136],"known":[138],"agent,":[140],"not":[142,165],"model.":[148],"vivo":[150,216],"studies":[151],"mouse":[153],"performance":[154],"on":[155,180],"an":[156],"accelerating":[157],"rotarod":[158],"hotplate":[160],"showed":[161,203],"did":[164],"induce":[166],"any":[167],"symptoms":[168],"peripheral":[170],"neuropathy.":[171],"addition,":[173],"we":[174],"evaluated":[175],"effect":[177],"permeability":[184,197],"transwell":[187],"system":[188],"confluent":[190],"HUVEC":[191],"monolayers.":[192],"resulted":[194],"increased":[196],"after":[198],"1":[199],"h":[200],"incubation":[201],"potency":[204],"similar":[205],"CA4.":[207],"summary,":[209],"potent":[211],"activities":[218],"suggest":[221],"it":[223],"may":[224],"represent":[225],"new":[227],"agent":[229],"for":[230,236,259],"management":[231],"solid":[233],"malignancies,":[234],"particularly":[235],"patients":[237],"drug":[239],"resistant":[240],"cancer.":[241],"Citation":[242],"Format:":[243],"{Authors}.":[244],"{Abstract":[245],"title}":[246],"[abstract].":[247],"In:":[248],"Proceedings":[249],"103rd":[252],"Annual":[253],"Meeting":[254],"American":[257],"Association":[258],"Cancer":[260,271],"Research;":[261],"2012":[262],"Mar":[263],"31-Apr":[264],"4;":[265],"Chicago,":[266],"IL.":[267],"Philadelphia":[268],"(PA):":[269],"AACR;":[270],"Res":[272],"2012;72(8":[273],"Suppl):Abstract":[274],"nr":[275],"2788.":[276],"doi:1538-7445.AM2012-2788":[277]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}